Nevin Örküş
38.3K posts







I'm 36. I'm a physician. I take a statin—and ezetimibe—every day. No symptoms. No cardiac history. Just an honest read of the evidence. Here's what I found—and why I stopped waiting for a reason to act.

Everyone's talking about retatrutide for weight loss (28.7%). Almost nobody's talking about what it does to your liver. More than 80% reduction in liver fat. Over 90% normalization rates. In a body composition substudy from the Phase 3 program. 100 million Americans have fatty liver disease. Most don't know it. There's no FDA-approved treatment for it besides "lose weight and hope." Retatrutide's glucagon receptor activation appears to directly target hepatic fat metabolism not just as a side effect of weight loss, but as a primary mechanism. This isn't a weight loss drug that happens to help your liver. It might be a liver drug that happens to cause weight loss. Phase 3 weight loss data drops first half of 2026. Watch this space.

Sayın Trendyol yetkilileri @Trendyol siz ne yapıyorsunuz.dünyada 3. Faz çalışması sonucu beklenen bir ilaç sitenizde satılıyor,hiç mi kontrol mekanizmanız yok?ilaç zaten satamazsınız ama bu ilaç daha yok





